Form 4: Corteva Director Kerry J. Preete Reports Acquisition of Shares and Dividend Reinvestment
SEC Form 4 Filing
Director Kerry J. Preete reports acquiring 3,100 shares of Corteva, Inc. common stock and additional shares through dividend reinvestment.
Summary
- On April 26, 2024, Kerry J. Preete, a director of Corteva, Inc., acquired 3,100 shares of common stock.
- The acquisition was made at a price of $0 per share.
- Preete also acquired 115.6246 shares through dividend reinvestment.
- Following these transactions, Preete directly owns 12,818.5554 shares of Corteva common stock.
- Preete also indirectly owns 2,500 shares through a revocable living trust.
Sentiment
Score: 6
Explanation: The sentiment is neutral to slightly positive. A director acquiring shares is generally a good sign, but the lack of specific details about the acquisition (e.g., if it was a grant or open market purchase) makes it difficult to assess the magnitude of the positive signal.
Positives
- The director's acquisition of shares could be seen as a positive signal, indicating confidence in the company's future performance.
Industry Context
Insider transactions are closely watched by investors as they can provide insights into management's perspective on the company's valuation and future prospects. Acquisitions are generally viewed more positively than sales.
Stakeholder Impact
- The reported transactions may have a minor positive impact on shareholder sentiment.
Key Dates
| Date | Description |
|---|---|
| 04/26/2024 | Date of transaction: Acquisition of Corteva common stock and dividend reinvestment. |
| 04/30/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.